Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2025-04-17 4:31 pm Purchase |
2025-04-10 | 13D | Xtant Medical Holdings, Inc. XTNT |
Nantahala Capital Management, LLC | 68,394,000 49.100% |
57,000,000![]() (+500.26%) |
Filing History |
2025-04-03 5:30 pm Unchanged |
2025-03-31 | 13D | Talphera, Inc. TLPH |
Nantahala Capital Management, LLC | 1,992,519 11.700% |
0 (Unchanged) |
Filing History |
2025-04-02 9:59 pm Unchanged |
2025-03-31 | 13D | Talphera, Inc. TLPH |
Nantahala Capital Management, LLC | 1,992,519 11.700% |
0 (Unchanged) |
Filing History |
2025-03-12 4:30 pm Purchase |
2025-03-10 | 13D | America's Car-Mart, Inc. CRMT |
Nantahala Capital Management, LLC | 644,686 7.800% |
100,000![]() (+18.36%) |
Filing History |
2025-02-19 4:32 pm Purchase |
2025-02-16 | 13G | Eagle Pharmaceuticals, Inc. EGRX |
Nantahala Capital Management, LLC | 4,945,209 38.078% |
1,000,000![]() (+25.35%) |
Filing History |
2025-02-14 4:32 pm Purchase |
2024-12-31 | 13G | Fossil Group, Inc. FOSL |
Nantahala Capital Management, LLC | 3,326,677 6.250% |
3,326,677![]() (New Position) |
Filing History |
2025-02-14 4:32 pm Purchase |
2024-12-31 | 13G | IMAX Corporation IMAX |
Nantahala Capital Management, LLC | 1,400,351 2.660% |
1,400,351![]() (New Position) |
Filing History |
2025-02-14 4:32 pm Purchase |
2024-12-31 | 13G | Inhibikase Therapeutics, Inc. IKT |
Nantahala Capital Management, LLC | 5,298,624 7.540% |
5,298,624![]() (New Position) |
Filing History |
2025-02-14 4:32 pm Purchase |
2024-12-31 | 13G | The ONE Group Hospitality, Inc. STKS |
Nantahala Capital Management, LLC | 2,087,394 6.770% |
403,321![]() (+23.95%) |
Filing History |
2025-02-14 4:32 pm Sale |
2024-12-31 | 13G | Peloton Interactive, Inc. PTON |
Nantahala Capital Management, LLC | 12,314,603 3.390% |
-6,328,728![]() (-33.95%) |
Filing History |
2025-02-14 4:32 pm Sale |
2024-12-31 | 13G | Rezolute, Inc. RZLT |
Nantahala Capital Management, LLC | 2,857,982 4.932% |
-2,108,735![]() (-42.46%) |
Filing History |
2025-02-14 4:32 pm Purchase |
2024-12-31 | 13G | Senti Biosciences, Inc. SNTI |
Nantahala Capital Management, LLC | 509,283 9.990% |
509,283![]() (New Position) |
Filing History |
2025-02-14 4:32 pm Purchase |
2024-12-31 | 13G | TELA Bio, Inc. TELA |
Nantahala Capital Management, LLC | 3,974,326 9.990% |
2,059,200![]() (+107.52%) |
Filing History |
2025-02-14 4:32 pm Purchase |
2024-12-31 | 13G | Verastem, Inc. VSTM |
Nantahala Capital Management, LLC | 4,523,184 9.990% |
470,980![]() (+11.62%) |
Filing History |
2025-02-14 4:32 pm Sale |
2024-12-31 | 13G | Zevra Therapeutics, Inc. ZVRA |
Nantahala Capital Management, LLC | 2,340,333 4.380% |
-583,688![]() (-19.96%) |
Filing History |
2025-02-14 4:32 pm Purchase |
2024-12-31 | 13G | Altisource Portfolio Solutions S.A. ASPS |
Nantahala Capital Management, LLC | 2,128,284 7.820% |
2,128,284![]() (New Position) |
Filing History |
2025-02-14 4:32 pm Purchase |
2024-12-31 | 13G | OptiNose, Inc. OPTN |
Nantahala Capital Management, LLC | 1,006,572 9.990% |
1,006,572![]() (New Position) |
Filing History |
2025-02-14 4:32 pm Purchase |
2024-12-31 | 13G | InspireMD, Inc. NSPR |
Nantahala Capital Management, LLC | 2,709,118 9.990% |
101,234![]() (+3.88%) |
Filing History |
2025-02-14 4:32 pm Purchase |
2024-12-31 | 13G | Surrozen, Inc. SRZN |
Nantahala Capital Management, LLC | 338,930 9.990% |
3,899![]() (+1.16%) |
Filing History |
2025-02-14 4:32 pm Purchase |
2024-12-31 | 13G | Soleno Therapeutics, Inc. SLNO |
Nantahala Capital Management, LLC | 4,349,435 9.990% |
398,148![]() (+10.08%) |
Filing History |